Orthopedic Roundup: Zimmer Biomet, J&J, Smith & Nephew, Stryker Hope For Post-COVID Recovery As Elective Surgeries Restart
The big four companies in the orthopedics space hope that the restart of elective surgeries will make up for lost sales, but many uncertainties remain.
You may also be interested in...
BIO Digital investment panel sees strong investment opportunities in telehealth, remote monitoring and converging digital products.
CMS Chief Advises Separate Non-COVID-19 Wards At Hospitals To Allow Device-Related Elective Surgeries To Resume
To get on with the business of providing non-coronavirus procedures – including elective surgeries involving replacement joints and other non-emergency care – at US health care facilities, Medicare agency chief Seema Verma is advising hospitals and outpatient facilities to establish non-COVID-19 care (NCC) zones.
Under guidelines recently unveiled by President Trump, US health care facilities could gradually start phasing-in more elective surgeries, including commonly performed operations that were postponed due the COVID-19 outbreak – many of which involve extensive device use. Elective surgeries include orthopedic joint replacement procedures, colonoscopies and cataract-correcting procedures that could resume as early as May under Trump’s plan.